COMP <GO>
ECPG vs BRK-B // EV/EBITDA & P/E VALUATION
Encore Capital Group Inc (NASDAQ) VS. Berkshire Hathaway Inc. (Class B) (NYSE) • 15-METRIC TALLY: ECPG 8
— BRK-B 2
▲ EV/EBITDA & P/E VALUATION LEADER: ECPG
LAST: $102.36 (+0.73%) • MKT CAP: $2.17B
valuation
3.1x
LAST: $541.96 (+0.30%) • MKT CAP: $1.20T
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECPG VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECPG | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 60.40% | 11.47% | +48.93 | ECPG | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 3.1x | 9.7x | -6.58 | ECPG | /valuation <GO> |
| Free Cash Flow Yield | 5.85% | 2.09% | +3.76 | ECPG | /fcf-yield <GO> |
| Operating Margin | 75.00% | 27.80% | +47.20 | ECPG | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 22.30% | +45.70 | ECPG | /net-margins <GO> |
| Revenue Growth (YoY) | 4.30% | 3.93% | +0.37 | ECPG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | ECPG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 3.55% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.8 | 67.7 | -17.87 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.61 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 7.8x | 24.3x | -16.54 | ECPG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.17B | $1.20T | -$1.19T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECPG REV | BRK-B REV | ECPG GROSS % | BRK-B GROSS % | ECPG FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $88.4M | $371.44B | — | — | $126.9M | $25.04B |
| FY 2024 | $84.8M | $371.43B | — | — | $127.2M | $11.62B |
| FY 2023 | $83.1M | $364.48B | — | — | $153.0M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECPG // BETA —
BRK-B // BETA 0.61